Publications
- Low incidence of factor VIII inhibitors in previously untreated patients with severe haemophilia A treated with octanate((R)): Final report from a prospective study2018 | Second Faculty of Medicine
- FVIII inhibitor development according to concentrate: Data from the EUHASS registry excluding overlap with other studies2016 | Second Faculty of Medicine
- Inhibitors incidence rate in Czech previously untreated patients with haemophilia A has not increased since introduction of recombinant factor VIII treatment in 20032015 | Second Faculty of Medicine
- Introduction of the treatment with recombinant FVIII has not increased the inhibitor incidence rate in Czech PUPs with haemophilia A2014 | Second Faculty of Medicine
- Response to the Letter to the Editor by Ewenstein BM and Reininger AJ2013 | Second Faculty of Medicine
- Low incidence of factor VIII inhibitors in previously untreated patients during prophylaxis, on-demand treatment and surgical procedures, with Octanate (R): interim report from an ongoing prospective clinical study2011 | Second Faculty of Medicine
- Severe congenital bleeding disorders manifesting in the neonatal period - case reports2022 | Second Faculty of Medicine
- Consensual guidelines of the Czech National Haemophilia Programme (CNHP) for the diagnosis and treatment of patients with haemophilia, 3rd edition, year 20212021 | Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Consensual guidelines of the Czech National Haemophilia Programme (CNHP) for the diagnosis and treatment of patients with congenital haemophilia and FVIII/ FIX inhibitors2021 | Second Faculty of Medicine, Faculty of Medicine in Pilsen
- A practical, one-clinic visit protocol for pharmacokinetic profile generation with the ADVATE(R) myPKFiT(R) dosing tool in severe hemophilia A subjects2021 | Second Faculty of Medicine
Loading network view...